Prophylaxis for Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients
A Stern, H Green, M Paul, L Vidal… - Cochrane database of …, 2014 - cochranelibrary.com
Background Pneumocystis pneumonia (PCP) is a disease affecting immunocompromised
patients. PCP among these patients is associated with significant morbidity and mortality …
patients. PCP among these patients is associated with significant morbidity and mortality …
[HTML][HTML] Current epidemiology of Pneumocystis pneumonia
A Morris, JD Lundgren, H Masur… - Emerging infectious …, 2004 - ncbi.nlm.nih.gov
Pneumocystis pneumonia (PCP) has historically been one of the leading causes of disease
among persons with AIDS. The introduction of highly active antiretroviral therapy in …
among persons with AIDS. The introduction of highly active antiretroviral therapy in …
Synthesis and evaluation of new coumarin derivatives as antioxidant, antimicrobial, and anti-inflammatory agents
HM Alshibl, ES Al-Abdullah, ME Haiba, HM Alkahtani… - Molecules, 2020 - mdpi.com
New pyranocoumarin and coumarin-sulfonamide derivatives were prepared and evaluated
for their antioxidant, antimicrobial, and/or anti-inflammatory activities. Coumarin-sulfonamide …
for their antioxidant, antimicrobial, and/or anti-inflammatory activities. Coumarin-sulfonamide …
[HTML][HTML] Cutaneous disease and drug reactions in HIV infection
SA Coopman, RA Johnson, R Platt… - New England journal of …, 1993 - Mass Medical Soc
Background Skin diseases, including adverse reactions to drugs, are thought to be more
common among patients with human immunodeficiency virus (HIV) infection and the …
common among patients with human immunodeficiency virus (HIV) infection and the …
CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection
H Masur, FP Ognibene, R Yarchoan… - Annals of internal …, 1989 - acpjournals.org
Study Objective: To determine if circulating CD4+ lymphocyte counts are predictive of
specific infectious or neoplastic processes causing pulmonary dysfunction. Design …
specific infectious or neoplastic processes causing pulmonary dysfunction. Design …
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine
JE Gallant, RD Moore, DD Richman… - Journal of Infectious …, 1992 - academic.oup.com
Data were analyzed from a multicenter observational cohort study of 1002 persons with
AIDS or AIDS-related complex (ARC) and total CD4 cell count< 0.25 x 109/L treated with …
AIDS or AIDS-related complex (ARC) and total CD4 cell count< 0.25 x 109/L treated with …
Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials
H Green, M Paul, L Vidal, L Leibovici - Mayo Clinic Proceedings, 2007 - Elsevier
OBJECTIVE To assess the efficacy of prophylaxis for Pneumocystis pneumonia (PCP),
caused by Pneumocystis jirovecii (formerly Pneumocystis carinii), for immunocompromised …
caused by Pneumocystis jirovecii (formerly Pneumocystis carinii), for immunocompromised …
[HTML][HTML] Accuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis
DE Karageorgopoulos, JM Qu, IP Korbila… - Clinical Microbiology …, 2013 - Elsevier
Pneumocystis jirovecii pneumonia (PCP) can affect various types of immunocompromised
patients. We sought to evaluate the diagnostic accuracy of (1→ 3)-β-D-glucan (BDG) for the …
patients. We sought to evaluate the diagnostic accuracy of (1→ 3)-β-D-glucan (BDG) for the …
Evolving epidemiology of pneumocystis pneumonia: Findings from a longitudinal population-based study and a retrospective multi-center study in Germany
B Kolbrink, J Scheikholeslami-Sabzewari… - The Lancet Regional …, 2022 - thelancet.com
Background Pneumocystis pneumonia (PCP) is a life-threatening opportunistic infectious
disease of immunocompromised patients. Its incidence has decreased worldwide in the …
disease of immunocompromised patients. Its incidence has decreased worldwide in the …
Sulfamethoxazole/Trimethoprim ratio as a new marker in raw wastewaters: A critical review
T Thiebault - Science of the total Environment, 2020 - Elsevier
Abstract Global Trimethoprim (TMP) and Sulfamethoxazole (SMX) occurrences in raw
wastewaters were systematically collected from the literature (n= 140 articles) in order to …
wastewaters were systematically collected from the literature (n= 140 articles) in order to …